GC Pharma Competitors and Similar CompaniesClear all

GC Pharma's competitors and similar companies include CSL Behring, Cadila Pharmaceuticals, UCB and Genentech.

	GC Pharma GC Pharma (formerly known as Green Cross Corporation, 녹십자) is a biopharmaceutical company that delivers protein therapeutics and vaccines.	CSL Behring CSL Behring is a provider of life-saving medicines.	Cadila Pharmaceuticals Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients.	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
Founding Date	Founding Date 1967	Founding Date 1904	Founding Date 1951	Founding Date 1928	Founding Date 1976
Type	Type Public	Type Subsidiary	Type Private	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Yongin-si, KR HQ	Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more	Locations Bavla, IN HQ Akaki, ET Dholka, IN Chiyoda City, JP Nairobi, KE Moskva, RU Ascot, GB see more	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more
Employees	Employees 2,016	Employees 7,5692% decrease	Employees 8,5201% increase	Employees 9,052	Employees 18,077
Financial
Revenue (est.)	Revenue (est.) ₩2t (FY, 2025)	Revenue (est.) $7.9b (FY, 2020)	Revenue (est.) N/A	Revenue (est.) €7.4b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods ₩1.4t (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods €1.4b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit ₩609.8b (FY, 2025)	Gross profit $4.5b (FY, 2020)	Gross profit N/A	Gross profit €7.2b (FY, 2025)	Gross profit N/A
Net income	Net income (₩29.7b) (FY, 2025)	Net income N/A	Net income N/A	Net income €1.6b (FY, 2025)	Net income N/A
Operating ⚠
Countries	Countries N/A	Countries 100 (Dec, 2020)	Countries N/A	Countries 35 (FY, 2019)	Countries N/A